Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2007
10/24/2007EP1847268A1 Multiple unit oral sustained release preparation and process for production of the same
10/24/2007EP1847264A1 Patch
10/24/2007EP1846457A1 Biodegradable hydrogels
10/24/2007EP1846445A1 Pyy agonists and uses thereof
10/24/2007EP1846428A1 Anti-inflammatory conjugates of macrolides and coumarins
10/24/2007EP1846042A2 Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications
10/24/2007EP1846040A2 Non-ionic non-aqueous vehicles for topical and oral administration of carrier-complexed active agents
10/24/2007EP1846039A2 Targeted chimeric molecules for cancer therapy
10/24/2007EP1846038A2 Conjugation of streptococcal capsular saccharides
10/24/2007EP1846037A1 Methods of treating various conditions by administration of sustained release l-arginine
10/24/2007EP1846014A2 Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally senstive transmembrane peptide
10/24/2007EP1846012A1 Stabilised plant extract and its therapeutic use
10/24/2007EP1846008A1 Method for the mitigation of symptoms of contact lens related dry eye
10/24/2007EP1846000A1 Pharmaceutical compositions containing bisphosphonate for improving oral absorption
10/24/2007EP1845787A2 Formulations for injection of catecholic butanes, including ndga compounds, into animals
10/24/2007EP1755630B1 Pharmaceutical compositions from beard lichen (usnea barbata) and st. john's wort (hypericum perforatum) and their use
10/24/2007EP1587517B1 Anti-protozoal compositions comprising diclazuril
10/24/2007EP1506041B1 Ibandronic acid for the treatment and prevention of osteoporosis
10/24/2007EP1478343A4 Compositions and methods for delivery of poorly water soluble drugs and methods of treatment
10/24/2007EP1471899B1 Use of ambroxol in the treatment of chronic pain
10/24/2007EP1312366B1 Gelling aqueous pharmaceutical compositions
10/24/2007EP1207860B1 Controlled release pellet formulation
10/24/2007EP1156797B1 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
10/24/2007CN101060886A Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy
10/24/2007CN101060862A Composition for oral or rectal administration
10/24/2007CN101060861A Method and composition for preventing or treating diarrhea
10/24/2007CN101060832A Nonaqueous liquid parenteral aceclofenac formulation
10/24/2007CN101058649A Stable nano gel with core-shell structure, preparation method and application thereof
10/24/2007CN101057973A Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof
10/24/2007CN101057972A Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof
10/24/2007CN101057968A Oxyntomodulin for preventing or treating excess weight
10/24/2007CN101057967A Stabilized interferon compositions
10/24/2007CN101057966A Liposome nanometer carrier situ gel preparation used for eye epidermal growth factor
10/24/2007CN101057963A Traditional Chinese medicine for treating scald and its preparation method
10/24/2007CN101057898A Compound filling agent for treating endometritis of cow and its preparation method
10/24/2007CN101057874A Method for comprehensively producing and utilizing nanometer biological active material
10/24/2007CN101057869A Pearl eyesight instant gel for eye
10/24/2007CN101057861A Polycarbophil enteric coated medicinal composition
10/24/2007CN101057858A Protecting agent for preventing and curing cow and goat mastitis and its preparation method
10/24/2007CN101057851A Improved entecavir effervescent tablet and its preparation method
10/24/2007CN101057849A Slow-releasing preparation containing metformin hydrochloride and glipizide and its preparation method
10/24/2007CN101057843A External applied spraying agent with tioconazole and its preparation method
10/24/2007CN101057841A 'Yanhuning' frozen-dried powder injection and its preparation method
10/24/2007CN101057835A Metformin glibenclamide slow-releasing preparation
10/24/2007CN101057834A Solid preparation comprising enteric solid dispersion
10/24/2007CN101057833A 固体分散体制剂 Solid dispersion formulations
10/24/2007CN101057832A Method for preparing protein or polypeptide medicine slow-releasing microball
10/24/2007CN101057831A Docetaxel liposome novel preparations and its preparation method
10/24/2007CN101057830A Naloxone hydrochloride sublingual spraying drug delivery system or composition and its preparation method
10/24/2007CN101057829A Supersaturated cationic self-emulsified drug delivery system and its preparation method
10/24/2007CN101057827A Palonosetron injection and its preparation method
10/24/2007CN101057826A Oryzanol injection with ethyl oleate as solvent and its preparation method
10/24/2007CN101057824A Injectable multimodal polymer depot compositions and uses thereof
10/24/2007CN100344677C 凝胶组合物 Gel compositions
10/24/2007CN100344648C Cyclosporine analogue mixtures and their use as immunomodulating agents
10/24/2007CN100344624C Pharmaceutical preparations containing arginine amides
10/24/2007CN100344611C 4-nitro-2-[(4'-methoxyl)-phenoxy]-toluenesulfonamide derivant and its medical uses
10/24/2007CN100344328C Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin
10/24/2007CN100344325C Medicine for treating cervical carcinoma, its preparation process and application
10/24/2007CN100344300C Cyclodextrin super molecular composition of Chinese medicine giant knutweed rhizome and its preparing method
10/24/2007CN100344293C Polymeric micelle containing cisplatin enclosed therein and use thereof
10/24/2007CN100344287C Biodegradable polyester fluorouracil microglobule and its preparation method
10/24/2007CN100344283C Abidor inclusion compound
10/24/2007CN100344278C Lasofoxifene tablet and its coating
10/24/2007CN100344277C Nano-magnetic medicinal microglobule, its preparation method and application
10/24/2007CA2586236A1 Compositions comprising co-precipitate of eplerenone and a water-soluble excipient
10/23/2007US7285661 Starch derivatives, starch active substance conjugates, method for the production thereof and their use as medicaments
10/23/2007US7285646 Has an iron binding capacity of at least 1.0 mg-per gram of protein, is non-pyrogenic and is pathogen free; preparation by anion exchange chromatography
10/23/2007US7285622 Hydrophilic polymer covalently yet reversibly linked to a amine-containing ligand through a dithiobenzyl linkage; modification of various substrates, such as polypeptides
10/23/2007US7285620 For selective modulation of leukocyte function, which is useful in a variety of inflammatory and autoimmune diseases, or in therapy of infections
10/23/2007US7285526 Reducing the interferon-bioavailability by administering two isolated interferon-binding proteins, e.g., the human IFN-gamma receptor; B8R and B18R proteins of Vaccinia virus; Alzheimer's disease; Down syndrome; HIV; autoimmune diseases
10/23/2007US7285517 Warming and nonirritating lubricant compositions and method of comparing irritation
10/23/2007US7285414 Viruses targeted to hypoxic cells and tissues
10/23/2007US7285381 Insertion in amino acid sequence of structural protein; purification, mutagenesis, genetic engineering; higher titers; gene therapy, cell transformation
10/23/2007US7285303 Powder material for electrostatic application to a substrate and electrostatic application of the powder material to a substrate
10/23/2007US7285298 Use of a dihydrochalcone-rich phenolic fraction in a cosmetic treatment
10/23/2007US7285282 Mucin peptide with immunoenhancing properties
10/23/2007US7285280 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; therapy
10/23/2007CA2406849C Stabilized liquid preparation
10/23/2007CA2391098C Recombinant .alpha.-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
10/23/2007CA2244209C Improved concentrated injection and infusion solutions for intravenous administration
10/23/2007CA2221900C Use of trospium chloride and 2-component system for the same
10/23/2007CA2181910C Process for making avermectin/zein compositions
10/23/2007CA2142981C Vaccines against group c neisseria meningitidis
10/18/2007WO2007117581A2 Stabilized transdermal bupropion preparations
10/18/2007WO2007117511A2 Feed formulations containing docosahexaenoic acid
10/18/2007WO2007117222A1 Biodegradable thermogelling polymer
10/18/2007WO2007117215A1 Binder for c-reactive protein
10/18/2007WO2007117173A1 Fluid dispensing system, methods and products
10/18/2007WO2007117023A1 Process and apparatus for producing liposome dispersion
10/18/2007WO2007117022A1 Chewing composition comprising coenzyme q10
10/18/2007WO2007116965A1 Fine particle containing graft polymer and calcium compound
10/18/2007WO2007116959A1 Microneedle device and transdermal administration device provided with microneedles
10/18/2007WO2007116916A1 Liquid drug preparation for oral administration
10/18/2007WO2007116915A1 Liquid drug preparation for oral administration packaged in a container having discharge unit
10/18/2007WO2007116808A1 Virus particle-like structure and pharmaceutical preparation comprising the same
10/18/2007WO2007116632A1 Microparticles, microparticle dispersion and method and apparatus for producing the same
10/18/2007WO2007116143A1 Bifunctionalized polysaccharides
10/18/2007WO2007115724A2 Method of increasing the in vivo recovery of therapeutic polypeptides
10/18/2007WO2007096906A3 Novel buccoadhesive compositions and process of preparation thereof
1 ... 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 ... 1712